Nippon India Pharma Fund (IDCW) Equity - Pharma
Plan: OPEN | Option: Dividend | Sailesh Raj Bhan
13 May 25 | 12:00 AM
114.50 1.15 (1.01%)
Critical Parameters
Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.
Returns
In last 1 year Nippon India Pharma Fund (IDCW), has underperformed BSE Healthcare TRI by -33.97% (CAGR difference)
14.35%
Underperforms
14 May 2024
Risk
In last 1 year , the volatility of Nippon India Pharma Fund (IDCW) is Lower than BSE Healthcare TRI by -0.12%
0.96%
Less Volatile
Risk Meter
Consistency
For out of Last 0 Months, i.e 0% of the times It underperformed its benchmark, Equity - Pharma
Consistency Meter
Outperforming Stocks Vs. Underperforming Stocks
Based on the last 1year analysis, currently there are, 16 Stocks beating the benchmark 19 Stocks not beating the benchmark